He made the comment while speaking during the Presidential task force briefing on COVID-19.
Ehanire said the government had imported the plant (artemisia) while trying to develop the production of artemisinin-based combination therapy (ACT) for anti-malaria some years ago.
He said the Madagascar herb is a component for the making of malaria drugs.
He, however, said the process has not made much progress, adding that further research would be carried out on the plant to check its effectiveness in treating COVID-19.
“Preliminary results of the analysis of the so-called Madagascar herbs or organics done by the National Institute for Pharmaceutical Research and Development (NIPRD) shows that it is the same as the plant called Artemisia anua, which is grown in the NIPRD farm in Abuja,” he said.
“Further research on its efficacy will be conducted when the grants for the research are approved.
“The so-called Madagascar herb is one component of the malaria treatment medicine.
“Some years ago, the government imported this plant and has a plantation of it in trying to develop its production of the artemisinin-based combination therapy (ACT).
“The plantation is still there, but the process has not gone that much further.
“We are looking into seeing what has held it up, but the plant is here; it was intended for producing anti-malarial, and the type we have here has a very high yield of artemisinin, which is the active ingredient.
“The species we have here have been tested and they have a very high concentration of artemisinin.
“To see whether it works against the coronavirus disease is what further research will have to bring.”
- US Restricts Students From Nigeria To Two-Year Courses - September 25, 2020
- Seyi Makinde Has Disappointed Oyo People – Adelabu - September 25, 2020
- Tory Lanez Clears Air On “Shooting Mega Thee Stallion” - September 25, 2020